ALLMedicine™ Keratoacanthoma Center
Research & Reviews 143 results
Dermatologic Therapy; Hamad J, Jolly PS
Sep 23rd, 2021 - Debulking followed by intralesional 5-fluorouracil (deb-IL5FU) is a non-surgical modality which has been used to treat skin cancer anecdotally for many years. There are few in depth studies examining this technique and success rate of intralesiona...
Journal of the American Academy of Dermatology; Lee JW, Cho KH et. al.
Sep 3rd, 2021 - Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study.|2021|Lee JW,Cho KH,Choi CW,Jo SJ,|
The American Journal of Dermatopathology;
Jun 5th, 2021 - Keratoacanthoma: Update on the Debate: Erratum.|2021||
Clinical and Experimental Dermatology; Liu LQ, Jiao T et. al.
Jun 3rd, 2021 - Irreversible blindness in generalized eruptive keratoacanthoma of Grzybowski.|2021|Liu LQ,Jiao T,Wang JY,|
Dermatology Online Journal; Xiao H, Hooper PB et. al.
Apr 19th, 2021 - Keratoacanthoma centrifugum marginatum (KCM) is an uncommon variant of keratoacanthoma. Keratoacanthoma centrifugum marginatums are most commonly seen on sun-exposed surfaces and present with progressive peripheral expansion and raised, hyperkerat...
News 18 results
Elizabeth Veasey, MD, Soon Bahrami, MD et. al.
Mar 2nd, 2020 - To the Editor: Basal cell carcinoma (BCC) is the most common of the nonmelanoma skin cancers and is a highly curable skin growth. 1,2 Conversely, angiosarcomas are aggressive vascular tumors of endothelial origin that classically appear as reddish.
Dawn Queen, BA, Lindsey E. Richards, MD et. al.
Oct 24th, 2019 - To the Editor: Keratoacanthoma (KA)–type squamous cell carcinomas (SCCs) are rapidly evolving neoplasms of the epithelium that often spontaneously regress but rarely metastasize. 1,2 Keratoacanthomas are thought to ascend from the hair follicle,1 a.
Reid A. Waldman, MD, Jane M. Grant-Kels, MD
Oct 3rd, 2019 - Practice Gap Management of nonmelanoma skin cancer (NMSC) in elderly patients can cause morbidity because these patients frequently struggle to care for their biopsy sites and experience biopsy- and surgery-related complications. To minimize this.
May 17th, 2019 - It is important to note that there have been no studies directly comparing the efficacy of the 3 approved BRAF/MEK inhibitor combinations, but the 3 different regimens have some differences in their toxicity profiles (Table 2). Of note, single-age.
The Journal of Family Practice;
Aug 23rd, 2018 - The FP suspected skin cancer, but was not sure if it was a basal cell carcinoma or a squamous cell carcinoma (SCC). The growth was somewhat pearly with telangiectasias, but there was also a prominent area of keratin on the posterior aspect of the.